These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2659567)

  • 1. Paradoxical resistance to ceftazidime and aztreonam in Proteus mirabilis.
    Salauze B; Petit JC
    J Antimicrob Chemother; 1989 Mar; 23(3):454-5. PubMed ID: 2659567
    [No Abstract]   [Full Text] [Related]  

  • 2. IMP-27, a Unique Metallo-β-Lactamase Identified in Geographically Distinct Isolates of Proteus mirabilis.
    Dixon N; Fowler RC; Yoshizumi A; Horiyama T; Ishii Y; Harrison L; Geyer CN; Moland ES; Thomson K; Hanson ND
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6418-21. PubMed ID: 27503648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of Proteus mirabilis isolates producing TEM-52 extended-spectrum beta-lactamases in Croatia.
    Sardelić S; Bedenić B; Sijak D; Colinon C; Kalenić S
    Chemotherapy; 2010; 56(3):208-13. PubMed ID: 20551637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a new extended-spectrum beta-lactamase (TEM-87) isolated in Proteus mirabilis during an Italian survey.
    Perilli M; Segatore B; De Massis MR; Franceschini N; Bianchi C; Rossolini GM; Amicosante G
    Antimicrob Agents Chemother; 2002 Mar; 46(3):925-8. PubMed ID: 11850290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The susceptibility of Proteus mirabilis strains isolated from white stork (Ciconia ciconia)].
    Kwiecińska-Piróg J; Bogiel T; Gospodarek E; Kasprzak M; Jerzak L; Kamiński P
    Med Dosw Mikrobiol; 2011; 63(2):139-44. PubMed ID: 22184908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.
    Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY
    J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of Ceftazidime-Avibactam against Extended-Spectrum- and AmpC β-Lactamase-Producing Enterobacteriaceae Collected in the INFORM Global Surveillance Study from 2012 to 2014.
    Karlowsky JA; Biedenbach DJ; Kazmierczak KM; Stone GG; Sahm DF
    Antimicrob Agents Chemother; 2016 May; 60(5):2849-57. PubMed ID: 26926635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The incidence of extended spectrum beta-lactamases in Proteus mirabilis strains isolated in 2007-2009].
    Kwiecińska-Piróg J; Bogiel T; Gospodarek E
    Przegl Epidemiol; 2010; 64(3):395-8. PubMed ID: 20976952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Ceftazidime-Avibactam and Aztreonam Overcome β-Lactam Resistance Conferred by Metallo-β-Lactamases in Enterobacteriaceae?
    Marshall S; Hujer AM; Rojas LJ; Papp-Wallace KM; Humphries RM; Spellberg B; Hujer KM; Marshall EK; Rudin SD; Perez F; Wilson BM; Wasserman RB; Chikowski L; Paterson DL; Vila AJ; van Duin D; Kreiswirth BN; Chambers HF; Fowler VG; Jacobs MR; Pulse ME; Weiss WJ; Bonomo RA
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28167541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of plasmid-encoded extended spectrum beta-lactamases produced by a clinical strain of Proteus mirabilis.
    Mahrouki S; Ben-Achour N; Chouchani C; Ben-Moussa M; Belhadj O
    Pathol Biol (Paris); 2009 May; 57(3):e55-9. PubMed ID: 18456422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Characterization of Carbapenem-Nonsusceptible Enterobacterial Isolates Collected during a Prospective Interregional Survey in France and Susceptibility to the Novel Ceftazidime-Avibactam and Aztreonam-Avibactam Combinations.
    Dupont H; Gaillot O; Goetgheluck AS; Plassart C; Emond JP; Lecuru M; Gaillard N; Derdouri S; Lemaire B; Girard de Courtilles M; Cattoir V; Mammeri H
    Antimicrob Agents Chemother; 2016 Jan; 60(1):215-21. PubMed ID: 26482307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies of synergistic interaction between aztreonam and cefoperazone.
    Borowski J; Zaremba M; Feliński J
    Chemioterapia; 1987 Jun; 6(2 Suppl):109-10. PubMed ID: 3151329
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of an inhibitor-resistant enzyme IRT-2 derived from TEM-2 beta-lactamase produced by Proteus mirabilis strains.
    Bret L; Chanal C; Sirot D; Labia R; Sirot J
    J Antimicrob Chemother; 1996 Aug; 38(2):183-91. PubMed ID: 8877532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of ceftazidime and ciprofloxacin on biofilm formation in Proteus mirabilis rods.
    Kwiecińska-Piróg J; Bogiel T; Gospodarek E
    J Antibiot (Tokyo); 2013 Oct; 66(10):593-7. PubMed ID: 23801185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of the mechanisms of decreased susceptibility of aztreonam-resistant and ceftazidime-resistant Enterobacteriaceae.
    Piddock LJ; Traynor EA; Wise R
    J Antimicrob Chemother; 1990 Dec; 26(6):749-62. PubMed ID: 2081717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VEB-6 extended-spectrum beta-lactamase-producing Proteus mirabilis from Sultanate of Oman.
    Potron A; Poirel L; Elhag K; Al Yaqoubi F; Nordmann P
    Int J Antimicrob Agents; 2009 Nov; 34(5):493-4. PubMed ID: 19525094
    [No Abstract]   [Full Text] [Related]  

  • 17. The in-vitro activity and beta-lactamase stability of carumonam.
    Neu HC; Chin NX; Labthavikul P
    J Antimicrob Chemother; 1986 Jul; 18(1):35-44. PubMed ID: 3531143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of ciprofloxacin in comparison with aztreonam, imipenem, and ceftazidime against multiply resistant strains.
    Nemes G; Stolle D; Nemes P
    Chemioterapia; 1987 Jun; 6(2 Suppl):133-5. PubMed ID: 3334552
    [No Abstract]   [Full Text] [Related]  

  • 19. Assessing the in vitro activity of ceftazidime/avibactam and aztreonam among carbapenemase-producing Enterobacteriaceae: Defining the zone of hope.
    Avery LM; Nicolau DP
    Int J Antimicrob Agents; 2018 Nov; 52(5):688-691. PubMed ID: 30044946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First description of DHA-1 ampCbeta-lactamase in Proteus mirabilis.
    Bidet P; Verdet C; Gautier V; Bingen E; Arlet G
    Clin Microbiol Infect; 2005 Jul; 11(7):591-2. PubMed ID: 15966982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.